BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19098407)

  • 1. [Fungal blood stream infection, its pathogen and antifungal susceptibility in cancer patients].
    Fujihara S; Imataki O; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2383-7. PubMed ID: 19098407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phaeohyphomycosis in a tertiary care cancer center.
    Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
    Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nosocomial fungal infections, analysis of 149 cases].
    Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez].
    Hernández-Dueñas AM; Vázquez-Larios Mdel R; Soto-Nieto GI; Rivera-Martínez E
    Rev Invest Clin; 2009; 61(4):294-9. PubMed ID: 19848306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular fungal isolates and antifungal susceptibility in northern China.
    Xuguang S; Zhixin W; Zhiqun W; Shiyun L; Ran L
    Am J Ophthalmol; 2007 Jan; 143(1):131-133. PubMed ID: 17188047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oliveira ER; Fothergill A; Kirkpatrick WR; Patterson TF; Redding SW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antifungal susceptibility testing in patient management.
    Forrest G
    Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Buchta V; Vejsova M; Vale-Silva LA
    Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal keratitis in London: microbiological and clinical evaluation.
    Galarreta DJ; Tuft SJ; Ramsay A; Dart JK
    Cornea; 2007 Oct; 26(9):1082-6. PubMed ID: 17893539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fungi in patients with diabetes mellitus type 2: prevalence, species of isolated strains].
    Maciejewska A; Jaskółowska A; Kwaśniewska J
    Wiad Parazytol; 2004; 50(2):163-70. PubMed ID: 16859020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
    Arredondo-García JL; Amábile-Cuevas CF;
    J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidaemia and antifungal susceptibility testing in a teaching hospital.
    Tzar MN; Shamim AS
    Med J Malaysia; 2009 Mar; 64(1):61-4. PubMed ID: 19852325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
    Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changing Trends in Isolation Frequencies and Species of Clinical Fungal Strains: What Do the 12-years (2008-2019) Mycology Laboratory Data Tell About?].
    Gülmez D; Sığ AK; Akar N; Duyan S; Arıkan Akdağlı S
    Mikrobiyol Bul; 2021 Jan; 55(1):53-66. PubMed ID: 33590981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer.
    Bagg J; Sweeney MP; Lewis MA; Jackson MS; Coleman D; Al MA; Baxter W; McEndrick S; McHugh S
    Palliat Med; 2003 Sep; 17(6):477-81. PubMed ID: 14526879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal drug resistance: mechanisms of resistance, freqeuncy, prevention and control of resistance].
    Mitrović SM; Dzamić AM; Arsić-Arsenijević VS; Radonjić IV; Kranjcić-Zec IF
    Srp Arh Celok Lek; 2007; 135(7-8):486-94. PubMed ID: 17929545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.
    Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU
    Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.